Ask My Investor AI
Public company · NYSEPublished company research
PNR

Legal name, ticker, exchange, reporting currency and CIK are verified from the FY2025 Form 10-K.

Pentair plc

Pentair sells direct PFAS reduction products through its Everpure commercial filtration line. The official product page identifies PFOA/PFOS systems certified by IAPMO against NSF/ANSI Standard 53. Q2 2026 sales were $933 million, but Pentair does not disclose PFAS-product revenue, orders or margins, so theme materiality is unresolved.

Ask follow-up research
Reviewed company research · researched 2026-07-29 · not an individual investment recommendation
Listing
public
Ticker
PNR
Exchange
NYSE
HQ
United Kingdom
Currency
USD
SEC CIK
0000077360
Investment case

How this company captures the theme economics

Competitive position

Pentair has branded commercial filtration distribution and certified point-of-use products. This is real product capability at the lighter end of the PFAS value chain, not direct exposure to municipal treatment, destruction or liability transfer.

Scarce assets

Everpure brand, commercial foodservice distribution, certified filtration media and installed customer relationships.

Products, segments, and customers

Pentair reports Flow, Water Solutions and Pool. Everpure PFAS reduction systems sit within water solutions, but PFAS is not a separately reported product or revenue line.

Theme capture

Pentair can capture consumer and commercial point-of-use PFAS mitigation demand through certified Everpure systems and replacement cartridges. Official sources do not establish product revenue or financial materiality.

Conditions

What must be true

  1. PFAS awareness must drive measurable Everpure system and cartridge demand.
  2. PFAS products must become meaningful within Water Solutions.

Identifiable catalysts

  • Issuer disclosure of PFAS-product demand or revenue.
  • Broader adoption of certified PFAS point-of-use filtration.
Theme materiality

2 mapped themes

Exposure statements are evidence-qualified. Materiality is only claimed where disclosure supports it.

Certified point-of-use commercial filtration systems and replacement cartridges for PFOA and PFOS reduction.

PFAS treatment, destruction and liability transfer

Direct product capability is verified by Pentair's Everpure PFAS reduction product page and system specification. Exposure is peripheral to municipal treatment and destruction, and issuer reporting does not isolate PFAS-product economics.

Evidence
Official Pentair product material directly supports PFOA/PFOS reduction capability and certification scope. FY2025 and Q2 2026 reporting supports issuer scale only.
Materiality
not assessed — No official source discloses PFAS-product revenue, orders, margins or installed-base economics; materiality fails closed as not assessed.
Water equipment and filtration provider.

Wastewater as a resource-recovery platform

Pentair's portfolio includes water equipment, but municipal wastewater resource-recovery exposure is not separately established.

Evidence
Official filings support consolidated segment structure only.
Materiality
not assessed — No issuer disclosure isolates theme-specific economics.
Financial evidence

Official SEC filing evidence

Reference period: Q2 2026.

  • Sales$933 million
    Q2 2026[2]
  • Operating income$167 million
    Q2 2026[2]
  • GAAP EPS$0.80
    Q2 2026[2]
  • Adjusted EPS$1.14
    Q2 2026[2]
  • Free cash flow$553 million
    Q2 2026[2]
  • Water Solutions sales$422.0 million
    Q2 2026[2]

Limitation: Current issuer reporting establishes consolidated and segment scale but not PFAS-product economics. Licensed current valuation remains unavailable.

Risks

Material risks and break conditions

Material risks

  • Pool channel volatility can dominate consolidated results.
  • PFAS point-of-use products may remain immaterial.
  • Certification or competitive changes can reduce product differentiation.

Thesis-break conditions

  • No measurable PFAS product adoption.
  • Water Solutions growth and margins deteriorate without offsetting demand.
Investability conclusion

Where the evidence lands

NOT_READY: official evidence verifies identity, current financials and certified PFAS products, but theme materiality and licensed current valuation remain unresolved. Human review is required before acceptance.

Next diligence

  1. Obtain official PFAS-product orders, revenue, margins and installed-base data.
  2. Connect licensed valuation data and complete human review.
Source ledger

Identity and evidence sources

Identity was verified against official issuer, filing, exchange, or regulator sources where available.

  1. Pentair plc FY2025 Form 10-KSEC EDGAR · primary · published 2026-02-24 · accessed 2026-07-29
  2. Pentair reports second quarter 2026 resultsPentair plc · primary · published 2026-07-28 · accessed 2026-07-29
  3. Everpure PFOA/PFOS reduction systemsPentair plc · primary · published n/a · accessed 2026-07-29
  4. Everpure QL3B-4FC-P system specificationPentair plc · primary · published n/a · accessed 2026-07-29